Roughly half of the drugs in clinical use today started as natural products — molecules that evolved inside microorganisms and plants that form the backbone of antibiotics, anti-cancer agents and other medicines.
The Natural Products Discovery Core connects U-M investigators and external partners to the chemistry of this microbial world, and to the expertise needed to develop that chemistry into novel drug leads.
Our library holds more than 50,000 extracts from marine and terrestrial actinomycetes, fungi and cyanobacteria collected worldwide, drawn from a collection of more than 11,000 microbial strains. Every extract is linked to its producing organism, so a screening hit can be traced to its source, regrown at scale and carried through to a defined chemical structure.
The core provides a complete discovery pipeline in one facility, from fermentation through structure elucidation and genome mining. Screening campaigns are run in partnership with the U-M Center for Chemical Genomics.